| Trademark Snap Shot Publication & Issue Review Stylesheet (Table presents the data on Publication & Issue Review Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 86705455 | FILING DATE | 07/27/2015 |
| REG NUMBER | 0000000 | REG DATE | 01/24/2017 |
| REGISTER | SUPPLEMENTAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | ZASKODA, ERIN RENE |
L.O. ASSIGNED | 103 |
PUB INFORMATION |
|||
| RUN DATE | 12/21/2016 | ||
| PUB DATE | N/A | ||
| STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
| STATUS DATE | 12/20/2016 | ||
| LITERAL MARK ELEMENT | LIVING DRUGS IN A BAG | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | 05/12/2016 | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | LIVING DRUGS IN A BAG |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | NantKwest, Inc. |
| ADDRESS | 2533 South Coast Highway 101 The Plastino Building, Suite 210 Cardiff-by-the Sea, CA 920072133 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Cells for clinical, medical, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic purposes |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, therapeutics and research related thereto |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/20/2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 028 |
| 12/13/2016 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 027 |
| 12/13/2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 026 |
| 12/13/2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 025 |
| 12/13/2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 024 |
| 12/13/2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 023 |
| 12/09/2016 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 022 |
| 12/08/2016 | IUAA | P | USE AMENDMENT ACCEPTED | 021 |
| 10/20/2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 020 |
| 10/20/2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 019 |
| 10/14/2016 | ALIE | A | ASSIGNED TO LIE | 018 |
| 10/05/2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 017 |
| 09/09/2016 | DOCK | D | ASSIGNED TO EXAMINER | 016 |
| 06/02/2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 015 |
| 06/02/2016 | GNRT | O | NON-FINAL ACTION E-MAILED | 014 |
| 06/02/2016 | CNRT | R | NON-FINAL ACTION WRITTEN | 013 |
| 05/13/2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 05/12/2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 05/12/2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 05/13/2016 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | 009 |
| 05/13/2016 | IUAF | S | USE AMENDMENT FILED | 008 |
| 05/12/2016 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | 007 |
| 11/12/2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 11/12/2015 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 11/12/2015 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 11/05/2015 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 07/31/2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 07/31/2015 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Alicia M. Passerin |
| CORRESPONDENCE ADDRESS | ALICIA M. PASSERIN Pietragallo Gordon Alfano Bosick & Raspa 1 Oxford Ctr Pittsburgh, PA 15219-1400 |
| DOMESTIC REPRESENTATIVE | NONE |